OptiBiotix Health Plc (OPTI)の価格はいくらですか

OptiBiotix Health Plc (OPTI)の価格は$0.07994122です

OptiBiotix Health Plc (OPTI)の時価総額は何ですか

OptiBiotix Health Plc (OPTI)の時価総額は$82.58Kです

OptiBiotix Health Plc（OPTI）PBR（株価純資産倍率）

OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United Kingdom, specializes in the discovery and advancement of microbiome-modulating technologies. The company formulates distinct microbial strains, innovative compounds, and tailored blends intended for integration into food products, nutritional supplements, and active ingredients. Their groundbreaking work aims to positively influence human physiology and yield substantial health benefits. Among its diverse product portfolio are Slimbiome, a natural ingredient for healthy and satiety-driven weight management, and SlimBiome Medical, a supplemental aid for weight control. Other offerings include CholBiome, a dietary supplement for maintaining healthy cholesterol; Lactobacillus plantarum LPLDL, a probiotic supporting cardiovascular health and overall well-being; LPGOS, a galactooligosaccharide utilized in food applications to mitigate cardiovascular risk factors and enhance general health; WellBiome, a functional fiber and mineral blend designed to bolster gut microbiome diversity and promote wellness; and Sweetbiotix, a sweetener for use in various foods and beverages. Ultimately, OptiBiotix's innovations are designed to prevent and manage prevalent chronic lifestyle diseases, including obesity, high cholesterol, and diabetes. The company was founded in 2012.

年	P/B比率	変化
2026 (TTM)	1.04	-50.35%
2024	2.10	-22.84%
2023	2.72	153.53%
2022	1.07	-51.71%
2021	2.22	-48.12%
2020	4.28	-62.38%
2019	11.38	3.97%
2018	10.94	27.05%
2017	8.61	-16.20%
2016	10.28	-37.65%
2015	16.49	1,187.68%
2014	1.28	11.90%
2013	1.14	-21.31%
2012	1.45	0.00%
2011	0.00	-100.00%
2010	0.36	4.78%
2009	0.34	1.84%
2008	0.34	0.00%
2007	0.00	0.00%

年

P/B比率

変化

2026 (TTM)

1.04

-50.35%

2024

2.10

-22.84%

2023

2.72

153.53%

2022

1.07

-51.71%

2021

2.22

-48.12%

2020

4.28

-62.38%

2019

11.38

3.97%

2018

10.94

27.05%

2017

8.61

-16.20%

2016

10.28

-37.65%

2015

16.49

1,187.68%

2014

1.28

11.90%

2013

1.14

-21.31%

2012

1.45

0.00%

2011

0.00

-100.00%

2010

0.36

4.78%

2009

0.34

1.84%

2008

0.34

0.00%

2007

0.00

0.00%

企業	P/B比率	P/B比率の差	国
Vertex Pharmaceuticals Incorporated VRTX.US	6.5144	524.76%	US
Moderna, Inc. MRNA.US	8.5918	724.00%	US
Argenx SE ARGX.US	7.3983	609.53%	NL
CSL Limited CSL.AX	3.9974	283.37%	AU
Lonza Group AG LONN.SW	-	-	CH

企業

P/B比率

P/B比率の差

国